Caroline Tillett - Dec 7, 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Dec 7, 2023
Transactions value $
$0
Form type
4
Date filed
12/11/2023, 05:13 PM
Previous filing
Oct 4, 2023
Next filing
Feb 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Award $0 +4.32K $0.00 4.32K Dec 7, 2023 Common Stock 4.32K Direct F1, F2
transaction KVUE Stock Options Award $0 +39.7K $0.00 39.7K Dec 7, 2023 Common Stock 39.7K $20.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These units correspond 1 for 1 with the Company's common stock.
F2 This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date.